Therapy-related AML after lung cancer is rare, but is associated with poor prognosis.
Although other flow cytometry–based prognostic scores have been proposed in the setting of MDS, their complexity has limited their clinical use.
Electronic medical records for more than 3500 survivors of pediatric malignancies were reviewed to determine number for whom cardiomyopathy screenings were recommended and rate of compliance with that recommendation.
Population-based study evaluated survival outcomes for patients with cancer diagnosed over a 41-year period.
Nearly half of all relapses occurred within the first month of CAR-T infusion.
HCT resulted in a lower risk of death among patients with high risk disease or if performed shortly after diagnosis, according to an observational study.
Two VA medical centers were each awarded one-time $50,000 grant funding to help them enroll veterans with cancer into clinical trials.
Peripheral T-cell lymphoma is characterized by extensive epigenetic dysregulation.
The risk for venous thromboembolism is steadily increasing among patients with cancer compared with the general population.
Researchers examined data from patients who were treated for Hodgkin lymphoma between 2009 and 2013 who had received radiation therapy as part of their treatment.
Patients with myelofibrosis conditioned with 2 alkylating agents may have better transplant outcomes compared with patients receiving 1 alkylating agent.
The approval was based on data from several clinical trials, including the phase 3 PACIFIC trial and the phase 3 CASPIAN trial.
Researchers report on status of immune response to influenza A vaccination, particularly memory cell clusters, in patients with myeloproliferative neoplasms.
A recent analysis of insurance claims data revealed trends in ED visits, ICU visits, hospitalizations, and antineoplastic treatment at the end of life in this population.
In a new study, researchers reported on the frequency of VTE among more than 6000 patients who tested positive for infection with SARS-CoV-2.
Researchers report on results with CAR-T therapy in real-world populations of patients with ALL or NHL.
Pfizer and BioNTech will submit an Emergency Use Authorization (EUA) request to the FDA for their mRNA-based vaccine candidate BNT162b2 against COVID-19.
Most study authors at the 2019 Society of Gynecologic Oncology Annual Meeting failed to disclose industry relationships, a study found.
Age, high-risk disease, renal disease, and active or progressive disease were predictive of worse outcomes for patients with multiple myeloma and COVID-19.
A literature review showed strategies for managing oral mucosal AEs in this patient population, including the role of dentists in a multidisciplinary team.